Nonalcoholic fatty liver disease is associated with cognitive function in adults

Sang Won Seo, Rebecca F. Gottesman, Jeanne M. Clark, Ruben Hernaez, Yoosoo Chang, Changsoo Kim, Kyoung Hwa Ha, Eliseo Guallar, Mariana Lazo

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Objective: We hypothesized that nonalcoholic fatty liver disease (NAFLD) is independently associated with cognitive impairment in a representative sample of the general US population regardless of the presence of cardiovascular disease (CVD) or its risk factors. Methods: This was a cross-sectional study of 4,472 adults aged 20-59 years who participated in the Third National Health and Nutritional Examination Survey. The participants underwent assessment of liver enzyme activity and hepatic steatosis by ultrasound, and underwent cognitive evaluation using the following computer-administered tests: the Simple Reaction Time Test (SRTT), the Symbol-Digit Substitution Test (SDST), and the Serial Digit Learning Test (SDLT). We defined NAFLD as moderate/severe steatosis as determined by ultrasound in the absence of hepatitis B or C or excessive alcohol consumption. We used multiple linear regression models to examine the association between NAFLD and cognitive function while controlling for potential confounders. Results: Participants with NAFLD showed lower overall performance on the SDLT (β 0.726, 95% confidence interval [CI] 0.105-1.347), while associations with SRTT and SDST did not reach significance. Increased activity of the liver enzymes alanine aminotransferase (β 0.018, 95% CI 0.006-0.030) and aspartate aminotransferase (β 0.021, 95% CI 0.005-0.037) correlated with lower performance on the SDLT, while increased alanine aminotransferase was also correlated with lower performance in the SDST (β 0.002, 95% CI 0.0001-0.004). Conclusions: NAFLD was independently associated with lower cognitive performance independent of CVD and its risk factors. Given the scarcity of risk factors associated with age-related cognitive decline, these findings may have significant implications.

Original languageEnglish
Pages (from-to)1136-1142
Number of pages7
JournalNeurology
Volume86
Issue number12
DOIs
Publication statusPublished - 2016 Mar 22

Fingerprint

Serial Learning
Cognition
Confidence Intervals
Alanine Transaminase
Reaction Time
Liver
Linear Models
Cardiovascular Diseases
Nutrition Surveys
Enzymes
Hepatitis C
Aspartate Aminotransferases
Hepatitis B
Alcohol Drinking
Cross-Sectional Studies
Non-alcoholic Fatty Liver Disease
Health
Population
Cognitive Dysfunction

All Science Journal Classification (ASJC) codes

  • Clinical Neurology

Cite this

Seo, S. W., Gottesman, R. F., Clark, J. M., Hernaez, R., Chang, Y., Kim, C., ... Lazo, M. (2016). Nonalcoholic fatty liver disease is associated with cognitive function in adults. Neurology, 86(12), 1136-1142. https://doi.org/10.1212/WNL.0000000000002498
Seo, Sang Won ; Gottesman, Rebecca F. ; Clark, Jeanne M. ; Hernaez, Ruben ; Chang, Yoosoo ; Kim, Changsoo ; Ha, Kyoung Hwa ; Guallar, Eliseo ; Lazo, Mariana. / Nonalcoholic fatty liver disease is associated with cognitive function in adults. In: Neurology. 2016 ; Vol. 86, No. 12. pp. 1136-1142.
@article{2a3fad1264184b1cb54c075d0dc9bc68,
title = "Nonalcoholic fatty liver disease is associated with cognitive function in adults",
abstract = "Objective: We hypothesized that nonalcoholic fatty liver disease (NAFLD) is independently associated with cognitive impairment in a representative sample of the general US population regardless of the presence of cardiovascular disease (CVD) or its risk factors. Methods: This was a cross-sectional study of 4,472 adults aged 20-59 years who participated in the Third National Health and Nutritional Examination Survey. The participants underwent assessment of liver enzyme activity and hepatic steatosis by ultrasound, and underwent cognitive evaluation using the following computer-administered tests: the Simple Reaction Time Test (SRTT), the Symbol-Digit Substitution Test (SDST), and the Serial Digit Learning Test (SDLT). We defined NAFLD as moderate/severe steatosis as determined by ultrasound in the absence of hepatitis B or C or excessive alcohol consumption. We used multiple linear regression models to examine the association between NAFLD and cognitive function while controlling for potential confounders. Results: Participants with NAFLD showed lower overall performance on the SDLT (β 0.726, 95{\%} confidence interval [CI] 0.105-1.347), while associations with SRTT and SDST did not reach significance. Increased activity of the liver enzymes alanine aminotransferase (β 0.018, 95{\%} CI 0.006-0.030) and aspartate aminotransferase (β 0.021, 95{\%} CI 0.005-0.037) correlated with lower performance on the SDLT, while increased alanine aminotransferase was also correlated with lower performance in the SDST (β 0.002, 95{\%} CI 0.0001-0.004). Conclusions: NAFLD was independently associated with lower cognitive performance independent of CVD and its risk factors. Given the scarcity of risk factors associated with age-related cognitive decline, these findings may have significant implications.",
author = "Seo, {Sang Won} and Gottesman, {Rebecca F.} and Clark, {Jeanne M.} and Ruben Hernaez and Yoosoo Chang and Changsoo Kim and Ha, {Kyoung Hwa} and Eliseo Guallar and Mariana Lazo",
year = "2016",
month = "3",
day = "22",
doi = "10.1212/WNL.0000000000002498",
language = "English",
volume = "86",
pages = "1136--1142",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

Seo, SW, Gottesman, RF, Clark, JM, Hernaez, R, Chang, Y, Kim, C, Ha, KH, Guallar, E & Lazo, M 2016, 'Nonalcoholic fatty liver disease is associated with cognitive function in adults', Neurology, vol. 86, no. 12, pp. 1136-1142. https://doi.org/10.1212/WNL.0000000000002498

Nonalcoholic fatty liver disease is associated with cognitive function in adults. / Seo, Sang Won; Gottesman, Rebecca F.; Clark, Jeanne M.; Hernaez, Ruben; Chang, Yoosoo; Kim, Changsoo; Ha, Kyoung Hwa; Guallar, Eliseo; Lazo, Mariana.

In: Neurology, Vol. 86, No. 12, 22.03.2016, p. 1136-1142.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Nonalcoholic fatty liver disease is associated with cognitive function in adults

AU - Seo, Sang Won

AU - Gottesman, Rebecca F.

AU - Clark, Jeanne M.

AU - Hernaez, Ruben

AU - Chang, Yoosoo

AU - Kim, Changsoo

AU - Ha, Kyoung Hwa

AU - Guallar, Eliseo

AU - Lazo, Mariana

PY - 2016/3/22

Y1 - 2016/3/22

N2 - Objective: We hypothesized that nonalcoholic fatty liver disease (NAFLD) is independently associated with cognitive impairment in a representative sample of the general US population regardless of the presence of cardiovascular disease (CVD) or its risk factors. Methods: This was a cross-sectional study of 4,472 adults aged 20-59 years who participated in the Third National Health and Nutritional Examination Survey. The participants underwent assessment of liver enzyme activity and hepatic steatosis by ultrasound, and underwent cognitive evaluation using the following computer-administered tests: the Simple Reaction Time Test (SRTT), the Symbol-Digit Substitution Test (SDST), and the Serial Digit Learning Test (SDLT). We defined NAFLD as moderate/severe steatosis as determined by ultrasound in the absence of hepatitis B or C or excessive alcohol consumption. We used multiple linear regression models to examine the association between NAFLD and cognitive function while controlling for potential confounders. Results: Participants with NAFLD showed lower overall performance on the SDLT (β 0.726, 95% confidence interval [CI] 0.105-1.347), while associations with SRTT and SDST did not reach significance. Increased activity of the liver enzymes alanine aminotransferase (β 0.018, 95% CI 0.006-0.030) and aspartate aminotransferase (β 0.021, 95% CI 0.005-0.037) correlated with lower performance on the SDLT, while increased alanine aminotransferase was also correlated with lower performance in the SDST (β 0.002, 95% CI 0.0001-0.004). Conclusions: NAFLD was independently associated with lower cognitive performance independent of CVD and its risk factors. Given the scarcity of risk factors associated with age-related cognitive decline, these findings may have significant implications.

AB - Objective: We hypothesized that nonalcoholic fatty liver disease (NAFLD) is independently associated with cognitive impairment in a representative sample of the general US population regardless of the presence of cardiovascular disease (CVD) or its risk factors. Methods: This was a cross-sectional study of 4,472 adults aged 20-59 years who participated in the Third National Health and Nutritional Examination Survey. The participants underwent assessment of liver enzyme activity and hepatic steatosis by ultrasound, and underwent cognitive evaluation using the following computer-administered tests: the Simple Reaction Time Test (SRTT), the Symbol-Digit Substitution Test (SDST), and the Serial Digit Learning Test (SDLT). We defined NAFLD as moderate/severe steatosis as determined by ultrasound in the absence of hepatitis B or C or excessive alcohol consumption. We used multiple linear regression models to examine the association between NAFLD and cognitive function while controlling for potential confounders. Results: Participants with NAFLD showed lower overall performance on the SDLT (β 0.726, 95% confidence interval [CI] 0.105-1.347), while associations with SRTT and SDST did not reach significance. Increased activity of the liver enzymes alanine aminotransferase (β 0.018, 95% CI 0.006-0.030) and aspartate aminotransferase (β 0.021, 95% CI 0.005-0.037) correlated with lower performance on the SDLT, while increased alanine aminotransferase was also correlated with lower performance in the SDST (β 0.002, 95% CI 0.0001-0.004). Conclusions: NAFLD was independently associated with lower cognitive performance independent of CVD and its risk factors. Given the scarcity of risk factors associated with age-related cognitive decline, these findings may have significant implications.

UR - http://www.scopus.com/inward/record.url?scp=84961644555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961644555&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000002498

DO - 10.1212/WNL.0000000000002498

M3 - Article

VL - 86

SP - 1136

EP - 1142

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 12

ER -